Partnerships & Research Pipeline
Structured partnerships and a focused portfolio of clinical research programs in regenerative medicine and related biomedical areas.
Structured partnerships and a focused portfolio of clinical research programs in regenerative medicine and related biomedical areas.
E2SMed is working in partnership with Cell-Innovations Pty Ltd to support the clinical research development of stem cell and other related bio-medicine programs.
Cell-Innovations brings experience in regenerative medicine technology development and clinical application pathways. E2SMed provides the clinical research investment, development and governance platform to support structured clinical evaluation and future commercial planning.
E2SMed is developing a focused portfolio of clinical research programs. Programs listed below may be at different stages of development and may be subject to ethics approval, regulatory assessment, funding, site activation, clinical trial registration and other approvals.
AreaSpinal and musculoskeletal research
StageClinical research program
StatusPhase II Clinical Trial
AreaOsteoarthritis Knee
StageCommercial
StatusPermitted in Australian hospitals under certain conditions
AreaCosmetic
StageCommercial
StatusPermitted in Australian hospitals under certain conditions
AreaBiomedical and medical technology programs
StageAssessment stage
StatusPartnership discussions
E2SMed works alongside a network of clinical and healthcare partners.
